Use of the Trypanosoma cruzi Recombinant Complement Regulatory Protein To Evaluate Therapeutic Efficacy following Treatment of Chronic Chagasic Patients

One of the greatest concerns in Chagas' disease is the absence of reliable methods for the evaluation of chemotherapy efficacy in treated patients. The tests available to evaluate cure after the specific treatment are the complement-mediated lysis (CoML) and flow cytometry tests, but they are not fe...

Deskribapen osoa

Xehetasun bibliografikoak

Argitaratua izan da:	J Clin Microbiol
Egile Nagusiak:	Meira, Wendell S. F., Galvão, Lúcia M. C., Gontijo, Eliane D., Machado-Coelho, George L. L., Norris, Karen A., Chiari, Egler
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	American Society for Microbiology (ASM) 2004
Gaiak:	Parasitology
Sarrera elektronikoa:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC344465/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/14766840/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JCM.42.2.707-712.2004
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!